A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 16, 2023

Primary Completion Date

February 22, 2024

Study Completion Date

March 7, 2024

Conditions
Pulmonary Fibrosis
Interventions
DEVICE

A wearable cough monitoring device, the Strados Labs RESPᵀᴹ sensor, with an accompanying mobile application (App) for data collection

A wearable cough monitoring device, the Strados Labs Remote Electronic Stethoscope Platform (RESP)ᵀᴹ sensor, with an accompanying mobile application (App) for data collection.

Trial Locations (13)

3500

Jessa Ziekenhuis - Campus Virga Jesse, Hasselt

8500

Kortrijk - HOSP AZ Groeninge Kennedylaan, Kortrijk

8800

Roeselare - HOSP AZ Delta, Roeselare

9300

Aalst - HOSP Onze-Lieve-Vrouw, Aalst

27103

Southeastern Research Center, Winston-Salem

29406

Lowcountry Lung and Critical Care, Charleston

79106

Universitätsklinikum Freiburg, Freiburg im Breisgau

80228

Critical Care, Pulmonary and Sleep Associates, Lakewood

89502

Renown Regional Medical Center, Reno

07747

Universitätsklinikum Jena, Jena

6815 AD

Rijnstate Hospital, Arnhem

4818 CK

Amphia Ziekenhuis, Breda

3015 CP

Erasmus Medisch Centrum, Rotterdam

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05670587 - A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device | Biotech Hunter | Biotech Hunter